A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock

Critical Care

Volumn 13, Issue 2, 2009, Pages

  Legras, Annick ^a   Giraudeau, Bruno ^b   Jonville Bera, Annie Pierre ^a   Camus, Christophe ^c   François, Bruno ^d   Runge, Isabelle ^e   Kouatchet, Achille ^f   Veinstein, Anne ^g   Tayoro, Jérome ^h   Villers, Daniel ⁱ   Autret Leca, Elisabeth ^a,b  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d LIMOGES UNIVERSITY HOSPITAL   (France)

^e Orleans Regional Hospital   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

^h CENTRE HOSPITALIER DU MANS   (France)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; DROTRECOGIN; NONSTEROID ANTIINFLAMMATORY AGENT; VASOPRESSIN;

ADULT; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SEPTIC SHOCK; TREATMENT DURATION; AGED; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RISK FACTORS; SEPSIS; SHOCK, SEPTIC;

EID: 65249165309     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7766     Document Type: Article

References (28)

1. Barnham MR Weightman NC Anderson AW Tanna A Streptococcal toxic shock syndrome: A description of 14 cases from North Yorkshire, UK Clin Microbiol Infect 2002, 8:174-181. 10.1046/j.1469-0691.2002.00396.x 12010172
2. Forbes N Ranklin AP Necrotizing fasciitis and non steroidal anti-inflammatory drugs: A case series and review of the literature N Z Med J 2001, 114:3-6. 11243676
3. Holder EP Moore PT Browne BA Nonsteroidal anti-inflammatory drugs and necrotising fasciitis. An update Drug Saf 1997, 17:369-373. 10.2165/ 00002018-199717060-00003 9429836
4. Mulla ZD Nonsteroidal anti-inflammatory drugs and hypotension among patients hospitalized for invasive Group A streptococcal disease Ann Epidemiol 2003, 13:543-4. 10.1016/S1047-2797(03)00071-1 12932632
5. Aronoff DM Bloch KC Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus Medicine 2003, 82:225-235. 10.1097/ 00005792-200307000-00001 12861100
6. Stevens DL Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995, 21:977-80. 8645850
7. Brun-Buisson CJ Saada M Trunet P Rapin M Roujeau JC Revuz J Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs Br Med J (Clin Res Ed) 1985, 290:1786. 10.1136/bmj.290.6484.1786 3924256 1415937
8. Rimailho A Riou B Richard C Auzepy P Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs J Infect Dis 1987, 155:143-146. 3540138
9. Schummer W Schummer C Nonsteroidal anti-inflammatory drugs and streptococcal toxic shock syndrome Intensive Care Med 2002, 28:1194. 10.1007/s00134-002-1376-5 12400522
10. Veenstra RP Manson WE Werf TS Fijen JW Tulleken JE Zijlstru JG Ligtenberg JJM Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs Intensive Care Med 2001, 27:1831. 10.1007/ s001340101070 11810132
11. Bone RC Balk RA Cerra FB Dellinger RP Fein AM Knaus WA Schein RM Sibbald WJ Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644 1303622
12. Levy MM Fink MP Marshall JC Abraham E Angus D Cook D Cohen J Opal SM Vincent JL Ramsay G 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 2003, 31:1250-1256. 10.1097/ 01.CCM.0000050454.01978.3B 12682500
13. Breslow NE Day NE Statistical Methods in Cancer Research. Volume I - The Analysis of Case-control Studies Lyon, France: IARC Scientific Publications; 1987.
14. O'Brien PC Fleming TR A multiple testing procedure for clinical trials Biometrics 1979, 35:549-556. 10.2307/2530245 497341
15. Gonzalez BE Martinez-Aguilar G Hulten KG Hammerman WA Coss-Bu J Avalos-Mishaan A Mason EO Kaplan SL Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant S. aureus Pediatrics 2005, 115:642-648. 10.1542/peds.2004-2300 15741366
16. Lesko SM O'Brien KL Schwartz B Vezina R Mitchell A Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella Pediatrics 2001, 107:1108-1115. 10.1542/ peds.107.5.1108 11331694
17. Peterson CL Vugia DJ Meyers HB Chao SM Vogt J Lanson J Brunell PA Kim KS Mascola L Risk factors for invasive group A streptococcal infections in children with varicella: A case-control study Pediatr Infect Dis J 1996, 15:151-156. 10.1097/00006454-199602000-00012 8822289
18. Mikaeloff Y Kezouh A Suissa S Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease Br J Clin Pharmacol 2008, 65:203-209. 10.1111/j.1365-2125.2007.02997.x 18251759 2291221
19. Zerr DM Alexander ER Duchin JS Koutzky LA Rubens CE A case-control study of necrotizing fasciitis during primary varicella Pediatrics 1999, 103:783-790. 10.1542/peds.103.4.783 10103303
20. Vincent JL Sakr Y Sprung CL Ranieri VM Reinhart K Gerlach H Moreno R Carlet J Le Gall JR Payen D on behalf of the Sepsis Occurrence in Acutely Ill Patients Investigators Sepsis in European intensive care units: Results of the SOAP study Crit Care Med 2006, 34:344-353. 10.1097/ 01.CCM.0000194725.48928.3A 16424713
21. Fletcher JR The effects of ibuprofen on eicosanoid synthesis in sepsis Crit Care Med 1999, 27:699-707. 10.1097/00003246-199904000-00001 10321658
22. Guibal F Muffat-Joly M Terris B Garry L Morel P Carbon C Effects of diclofenac on experimental streptococcal necrotizing fasciitis in rabbit Arch Dermatol Res 1998, 290:628-633. 10.1007/s004030050363 9860284
23. Kumar A Roberts D Wood KE Light B Parrillo JE Sharma S Suppes R Feinstein D Zanotti S Taiberg L Gurka D Kumar A Cheang M Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9 16625125
24. Bernard GR Wheeler AP Russell JA Schein R Summer WR Steinberg KP Fulkerson WJ Wright PE Christman BW Dupont WD Higgins SB Swindell BB for the Ibuprofen in Sepsis Study Group The effects of ibuprofen on the physiology and survival of patients with sepsis N Engl J Med 1997, 336:912-918. 10.1056/NEJM199703273361303 9070471
25. Haupt MT Jastremski MS Clemmer TP Metz CA Goris GB the Ibuprofen Study Group Effect of ibuprofen in patients with severe sepsis: A randomized double blind study Crit Care Med 1991, 19:1339-1347. 1935150
26. Memis D Karamanlioglu B Turan A Koyuncu O Pamukcu Z Effects of lornoxicam on the physiology of severe sepsis Crit Care 2004, 8:R474-R482. 1065065 15566594 10.1186/cc2969
27. Coran AG Drongowski RA Paik JJ Remick DG Ibuprofen intervention in canine septic shock: Reduction of pathophysiology without decreased cytokines J Surg Res 1992, 53:272-279. 10.1016/0022-4804(92)90047-4 1326683
28. Martich GD Danner RL Ceska M Suffredini F Detection of IL8 and TNF in normal humans after IV endotoxin: The effect of antiinflammatory agents J Exp Med 1991, 173:1021-1024. 2190822 2007851 10.1084/jem.173.4.1021